Malin Corporation plc
Malin Corporation plc MLC.IR Peers
See (MLC.IR) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MLC.IR | $8.20 | -5.75% | 160.93M | -205.00 | -$0.04 | N/A |
| IPN.PA | $104.40 | +2.65% | 8.63B | 24.45 | $4.27 | +1.15% |
| FAGR.BR | $21.20 | -0.70% | 1.54B | 19.27 | $1.10 | +1.42% |
| VETO.PA | $72.90 | -0.27% | 860.18M | 14.64 | $4.98 | +1.17% |
| BOI.PA | $25.00 | +1.21% | 434.06M | 38.46 | $0.65 | +5.40% |
| AB.PA | $1.46 | -0.27% | 84.55M | -20.89 | -$0.07 | N/A |
| MITRA.BR | $0.22 | N/A | 14.45M | -0.15 | -$1.41 | N/A |
| ALRPD.PA | $0.01 | -3.57% | 811467.00 | -0.28 | -$0.02 | N/A |
| MLGML.PA | $0.04 | -20.00% | 536272.00 | -0.80 | -$0.05 | N/A |
Stock Comparison
MLC.IR vs IPN.PA Comparison
MLC.IR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLC.IR stands at 160.93M. In comparison, IPN.PA has a market cap of 8.63B. Regarding current trading prices, MLC.IR is priced at $8.20, while IPN.PA trades at $104.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLC.IR currently has a P/E ratio of -205.00, whereas IPN.PA's P/E ratio is 24.45. In terms of profitability, MLC.IR's ROE is +0.00%, compared to IPN.PA's ROE of +0.08%. Regarding short-term risk, MLC.IR is more volatile compared to IPN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for MLC.IR.